IFM Therapeutics looks to inhibit STING to treat autoimmune disease
Monday, February 11, 2019 - 07:50
in Health & Medicine
The Boston firm, which previously developed STING activators for cancer immunotherapy, now plans to tackle the same drug target for different diseases